
Adjuvant Capital
North America, New York, United States, New York
Description
Adjuvant Capital is a life sciences investment firm focused on global health.
Investor Profile
Adjuvant Capital has made 33 investments, with 1 in the past 12 months and 36% as lead.
Stage Focus
- Series A (30%)
- Series B (27%)
- Series C (18%)
- Series D (9%)
- Series Unknown (6%)
- Convertible Note (3%)
- Series E (3%)
- Post Ipo Debt (3%)
Country Focus
- United States (61%)
- Switzerland (12%)
- Denmark (9%)
- United Kingdom (6%)
- Belgium (6%)
- China (3%)
- Austria (3%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Life Science
- Biopharma
- Genetics
- Manufacturing
- Therapeutics
- Wellness
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.